Showing results (2341-2350 of 3,095) with videos related to

Sort By:
Pageof 310
Clinical Kidney Journal|May 7, 2021
Pharmacoepidemiology for nephrologists (part 2): potential biases and how to overcome themEdouard L Fu, Merel van Diepen, Yang Xu, et al.
Clinical Kidney Journal|May 7, 2021
Cell-free DNA as a marker for the outcome of end-stage renal disease patients on haemodialysisSusana Coimbra, Susana Rocha, Henrique Nascimento, et al.
Clinical Kidney Journal|May 7, 2021
Acute kidney disease and long-term outcomes in critically ill acute kidney injury patients with sepsis: a cohort analysisJoana Gameiro, Carolina Carreiro, José Agapito Fonseca, et al.
Clinical Kidney Journal|May 13, 2021
Exercise training in chronic kidney disease-effects, expectations and adherenceNaomi Clyne, Kirsten Anding-Rost
Clinical Kidney Journal|April 17, 2020
The association of socioeconomic status with incidence and outcomes of acute kidney injuryHilda O Hounkpatin, Simon D S Fraser, Matthew J Johnson, et al.
Clinical Kidney Journal|September 3, 2021
Low dialysis potassium bath is associated with lower mortality in end-stage renal disease patients admitted to hospital with severe hyperkalemiaTripti Singh, Sayee Alagasundaramoorthy, Andrew Gregory, et al.
Clinical Kidney Journal|September 3, 2021
Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trialChristoph Wanner, Mark E Cooper, Odd Erik Johansen, et al.
Clinical Kidney Journal|May 29, 2015
Acute kidney injury in dengue virus infectionMuhammad A M Khalil, Sarfaraz Sarwar, Muhammad A Chaudry, et al.
Clinical Kidney Journal|May 29, 2015
Minimal-change disease secondary to etanerceptMariko Koya, Raimund Pichler, J Ashley Jefferson
Clinical Kidney Journal|May 29, 2015
Discrete renal deposition of IgM heavy chain and κ light chain in Waldenström macroglobulinemia (IgM-κ)Atsushi Komatsuda, Rie Masai, Masaru Togashi, et al.
Pageof 310